Literature DB >> 20080953

Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

Caryn S Ross-Innes1, Rory Stark, Kelly A Holmes, Dominic Schmidt, Christiana Spyrou, Roslin Russell, Charlie E Massie, Sarah L Vowler, Matthew Eldridge, Jason S Carroll.   

Abstract

Retinoic acid receptor-alpha (RAR alpha) is a known estrogen target gene in breast cancer cells. The consequence of RAR alpha induction by estrogen was previously unknown. We now show that RAR alpha is required for efficient estrogen receptor-alpha (ER)-mediated transcription and cell proliferation. RAR alpha can interact with ER-binding sites, but this occurs in an ER-dependent manner, providing a novel role for RAR alpha that is independent of its classic role. We show, on a genome-wide scale, that RAR alpha and ER can co-occupy regulatory regions together within the chromatin. This transcriptionally active co-occupancy and dependency occurs when exposed to the predominant breast cancer hormone, estrogen--an interaction that is promoted by the estrogen-ER induction of RAR alpha. These findings implicate RAR alpha as an essential component of the ER complex, potentially by maintaining ER-cofactor interactions, and suggest that different nuclear receptors can cooperate for effective transcriptional activity in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080953      PMCID: PMC2807352          DOI: 10.1101/gad.552910

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  47 in total

1.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles.

Authors:  Albin Sandelin; Wynand Alkema; Pär Engström; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

3.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

4.  Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer.

Authors:  C K Glass; S M Lipkin; O V Devary; M G Rosenfeld
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

5.  A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

Authors:  Jérôme Eeckhoute; Jason S Carroll; Timothy R Geistlinger; Maria I Torres-Arzayus; Myles Brown
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

Review 6.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

7.  Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer.

Authors:  R A McClelland; J M Gee; A B Francis; J F Robertson; R W Blamey; A E Wakeling; R I Nicholson
Journal:  Eur J Cancer       Date:  1996-03       Impact factor: 9.162

Review 8.  Nuclear retinoid receptors and the transcription of retinoid-target genes.

Authors:  Julie Bastien; Cécile Rochette-Egly
Journal:  Gene       Date:  2004-03-17       Impact factor: 3.688

9.  Genome-wide mapping of in vivo protein-DNA interactions.

Authors:  David S Johnson; Ali Mortazavi; Richard M Myers; Barbara Wold
Journal:  Science       Date:  2007-05-31       Impact factor: 47.728

10.  New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

Authors:  Charles E Massie; Boris Adryan; Nuno L Barbosa-Morais; Andy G Lynch; Maxine G Tran; David E Neal; Ian G Mills
Journal:  EMBO Rep       Date:  2007-08-17       Impact factor: 8.807

View more
  121 in total

1.  Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response.

Authors:  Christine Ferry; Samia Gaouar; Benoit Fischer; Marcel Boeglin; Nicodeme Paul; Eric Samarut; Aleksandr Piskunov; Gabriella Pankotai-Bodo; Laurent Brino; Cecile Rochette-Egly
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

2.  Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.

Authors:  Natalia Ryan; Brian Chorley; Raymond R Tice; Richard Judson; J Christopher Corton
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

3.  Stromal retinoic acid receptor beta promotes mammary gland tumorigenesis.

Authors:  Xingxing Liu; Mélanie Nugoli; Julie Laferrière; Sadiq M Saleh; Ian G Rodrigue-Gervais; Maya Saleh; Morag Park; Michael T Hallett; William J Muller; Vincent Giguère
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 4.  Functional genomic methods to study estrogen receptor activity.

Authors:  Siv Gilfillan; Elisa Fiorito; Antoni Hurtado
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-05-16       Impact factor: 2.673

5.  DMRT1 protects male gonadal cells from retinoid-dependent sexual transdifferentiation.

Authors:  Anna Minkina; Clinton K Matson; Robin E Lindeman; Norbert B Ghyselinck; Vivian J Bardwell; David Zarkower
Journal:  Dev Cell       Date:  2014-05-22       Impact factor: 12.270

6.  Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells.

Authors:  Shubha M Hegde; M Naveen Kumar; K Kavya; K M Kiran Kumar; Rashmi Nagesh; Rajeshwari H Patil; R L Babu; Govindarajan T Ramesh; S Chidananda Sharma
Journal:  Mol Cell Biochem       Date:  2016-09-08       Impact factor: 3.396

7.  Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.

Authors:  Jessica Finlay-Schultz; Austin E Gillen; Heather M Brechbuhl; Joshua J Ivie; Shawna B Matthews; Britta M Jacobsen; David L Bentley; Peter Kabos; Carol A Sartorius
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

Review 8.  Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.

Authors:  Roisin M Connolly; Nguyen K Nguyen; Saraswati Sukumar
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

9.  Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.

Authors:  Hideo Watanabe; Joshua M Francis; Michele S Woo; Banafsheh Etemad; Wenchu Lin; Daniel F Fries; Shouyong Peng; Eric L Snyder; Purushothama Rao Tata; Francesca Izzo; Anna C Schinzel; Jeonghee Cho; Peter S Hammerman; Roel G Verhaak; William C Hahn; Jayaraj Rajagopal; Tyler Jacks; Matthew Meyerson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

10.  Cooperative Dynamics of AR and ER Activity in Breast Cancer.

Authors:  Nicholas C D'Amato; Michael A Gordon; Beatrice Babbs; Nicole S Spoelstra; Kiel T Carson Butterfield; Kathleen C Torkko; Vernon T Phan; Valerie N Barton; Thomas J Rogers; Carol A Sartorius; Anthony Elias; Jason Gertz; Britta M Jacobsen; Jennifer K Richer
Journal:  Mol Cancer Res       Date:  2016-08-26       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.